Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (191-200 of 279) with videos related to

Pageof 28
Sort By:
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Science Translational Medicine|June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's diseaseAura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Nature Medicine|January 16, 2019
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunctionDaniel A Nation, Melanie D Sweeney, Axel Montagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2023
Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's diseaseChengjie Xiong, Lena M McCue, Virginia Buckles, et al.
Neurology|April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament LightSuzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2020
Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learningNicolai Franzmeier, Nikolaos Koutsouleris, Tammie Benzinger, et al.
Science Translational Medicine|March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's diseaseAnne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Pageof 28

Showing results (191-200 of 279) with videos related to

Sort By:
Pageof 28
JAMA Neurology|January 31, 2022
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer DiseaseYen Ying Lim, Paul Maruff, Nicolas R Barthélemy, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Science Translational Medicine|June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's diseaseAura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Nature Medicine|January 16, 2019
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunctionDaniel A Nation, Melanie D Sweeney, Axel Montagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2023
Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's diseaseChengjie Xiong, Lena M McCue, Virginia Buckles, et al.
Neurology|April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament LightSuzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2020
Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learningNicolai Franzmeier, Nikolaos Koutsouleris, Tammie Benzinger, et al.
Science Translational Medicine|March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's diseaseAnne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Pageof 28